Skip to content
Black Week: 20% off everything, code BLACK

Search

What are you looking for?

Type at least 2 characters to see suggestions.

TRIPLE G 10mg PEN
TRIPLE G 10mg PEN
TRIPLE G 10mg PEN
TRIPLE G 10mg PEN

TRIPLE G 10mg PEN

Triple G 10mg pen is an innovative research peptide that is the subject of intensive clinical trials around the world. Unlike previous substances from this group, retatrutide acts simultaneously on three hormonal receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon. It is this triple activity that makes this substance arouse great interest in the scientific community.

135,99 €
With code BLACK: 108,79 € Lowest price in the 30 days before the discount: 135,99 €
Buy more, pay less
Fast shipping
Free delivery from 350 €
Returns policy
Peptide Calculator

TRIPLE G 10mg PEN - research reagent

  • TRIPLE G (retatrutide): a research reagent.
  • PEN format; content: 10 mg.
  • Material intended exclusively for scientific research.

TRIPLE G 10mg PEN is a high-purity peptide substance offered as a reference material intended only for research and laboratory applications. The product contains retatrutide – a synthetic peptide analogue, which is the subject of intensive scientific research conducted by academic centers and research institutions around the world. This document presents the chemical characteristics, physicochemical properties and potential research applications of this substance. All information is for scientific and educational purposes only, based on published laboratory and preclinical research results.

TRIPLE G 10mg PEN is a chemical reagent supplied in a sterile dosing device. This form ensures the convenience of preparing research solutions and the precision of dosing necessary in laboratory work. The product qualifies as a reference material authorized for marketing in the European Union in accordance with applicable regulations on chemicals used in scientific research.

Each pen contains 10 mg of active substance with a high degree of purity, which allows you to conduct precise research experiments requiring repeatability of results. Check out the bigger ones too 20 mg pack

What is Triple G 10 mg pen?

Retatrutide (laboratory designation: LY3437943) is a synthetic peptide belonging to the class of triple receptor agonists. This molecule was designed to interact simultaneously with three types of G-protein-coupled receptors: the GLP-1 (glucagon-like peptide-1) receptor, the GIP (glucose-dependent insulinotropic polypeptide) receptor, and the glucagon receptor.

In the context of chemical classification, retatrutide is a structurally modified peptide containing an amino acid sequence designed to enable multireceptor binding. This substance is the subject of publications in peer-reviewed scientific journals and is intensively researched in terms of its biochemical properties and potential applications in in vitro and in vivo research models.

Structure and chemical properties

Molecular structure

Retatrutide is a peptide of approximately 39 amino acids whose structure has been optimized for affinity to three types of receptors. The molecule contains structural modifications typical of peptides with extended half-life, including acylation with a fatty acid lipid chain.

Basic physicochemical data:

  • Molecular weight: approximately 4200 Da
  • Physical form: white to cream-colored freeze-dried powder
  • Solubility: soluble in water and buffer solutions with physiological pH
  • Stability: stable substance in the freeze-dried state under appropriate storage conditions

Mechanism of receptor binding

The structure of retatrutide has been designed to enable interaction with three types of receptors:

  1. GLP-1 receptor – binding occurs through a specific amino acid sequence homologous to natural GLP-1
  2. GIP receptor – fragments of the molecule show affinity for the GIP receptor
  3. Glucagon receptor – structural modifications enable activation of the glucagon receptor

Purity and analysis

Quality parameters

TRIPLE G 10mg PEN is characterized by a high degree of purity necessary to conduct reliable scientific research. The product is subjected to multi-stage quality control including:

  • HPLC analysis – high-performance liquid chromatography confirming the purity of the peptide at a minimum level of 98%
  • Mass spectrometry – verification of molecular weight and peptide structure
  • Peptide content analysis – determination of the actual content of the active substance
  • Tests for the presence of endotoxins – testing the sterility of the preparation

Storage and handling

Storage conditions

Correct storage of retatrutide is fundamental to maintaining the stability and research properties of the substance:

  • Storage temperature: 2°C to 8°C (laboratory cold store)
  • Light protection: UV-sensitive substance
  • Humidity: store in a dry place, in a tightly closed container
  • Shelf life: up to 24 months in a freeze-dried state under storage conditions

Preparation of the test solution

After reconstitution of the substance, it is recommended:

  • Use of sterile water for injection or appropriate buffer
  • Slow dissolution by gently swirling the vial (avoid shaking)
  • Store the solution at a temperature of 2-8°C for up to 7 days
  • Possibility of freezing single-use portions at -20°C

Security measures

Working with retatrutide requires following standard laboratory safety procedures:

  • Use of personal protective equipment (gloves, safety glasses, laboratory coat)
  • Work in sterile conditions when preparing solutions
  • Proper disposal of used materials in accordance with local regulations
  • Documenting all research procedures

Action of retetrutide

Interaction with G-protein-coupled receptors

In vitro studies have shown that retatrutide acts as an agonist of three types of receptors belonging to the G protein-coupled receptor (GPCR) family. The mechanism of action at the molecular level includes: GLP-1 receptor activation: In studies on cell lines expressing the GLP-1 receptor, activation of the cAMP/PKA signaling pathway was observed after exposure to retatrutide. This activation leads to a signaling cascade characteristic of the natural ligand GLP-1.

GIP receptor activation: In vitro experiments confirmed the ability of retatrutide to activate GIP receptors, which is manifested by an increase in the intracellular concentration of cyclic AMP and the activation of protein kinase A.

Glucagon receptor activation: Studies on hepatocytes and cell lines expressing the glucagon receptor have shown that retatrutide induces a cellular response characteristic of activation of this receptor.

Selectivity and affinity

Data from in vitro studies indicate varying affinity of retatrutide for particular types of receptors:

  • GLP-1 receptor: full agonist activation
  • GIP receptor: agonist activation with potency comparable to natural GIP
  • Glucagon receptor: partial to full agonist activation

Used in research

Research on receptor signaling

Retatrutide is a valuable tool in research on the molecular mechanisms of GLP-1, GIP and glucagon receptor signaling. This substance allows the analysis of:

  • Interactions between different signaling pathways
  • Synergistic effects of simultaneous activation of multiple receptors
  • Mechanisms of receptor desensitization

Cell models of metabolism

In studies using cell lines (adipocytes, hepatocytes, pancreatic beta cells), retatrutide can be used to:

  • Analyzes of the effect on glucose metabolism in vitro
  • Gene expression studies related to lipid metabolism
  • Assessment of the effect on insulin secretion from isolated pancreatic islets

Pharmacological studies

Pharmaceutical and academic laboratories use retatrutide as:

  • Reference substance in the development of new peptide compounds
  • Comparative material in studies on other receptor agonists
  • Subject of ADME studies (absorption, distribution, metabolism, elimination)

Biochemical analyses

Retatrutide is used in:

  • Development of analytical methods (HPLC, MS)
  • Validation of laboratory procedures
  • Peptide stability studies

Summary

TRIPLE G 10mg PEN with retatrutide is a high-quality reference material intended exclusively for research and laboratory applications. This substance represents a class of triple receptor agonists and is the subject of intensive scientific research conducted around the world.

All information contained in this document is for scientific and educational purposes only. The product is not a medicine, dietary supplement or food. It has not been approved for use in humans or animals outside of controlled scientific studies.

Scientific References

  1. Coskun T, et al. (2022). “LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.” Cell Metabolism.
  2. Finan B, et al. (2015). “A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.” Nature Medicine.
  3. Jastreboff AM, et al. (2023). “Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 Trial.” The New England Journal of Medicine.